Filter posts

Drug Importation: Dangerous for Patients, Consumers, and American Communities

Writing for The Hill, Steve Forbes, Forbes Media Chairman and Editor in Chief, delivered a …

Senate Has the Power to Expand Access to Medication for Opioid Addiction

BIO President and CEO Jim Greenwood posted the following op-ed on Linked-In today, making the …

Next Generation Approaches to Battling Pain and Addiction

What are the new and emerging scientific insights and approaches that offer hope for non-addictive …

Secretary Azar Talks Opioid Strategy with NGA

Recently, HHS Secretary Alex Azar joined the National Governors Association to discuss opioid addiction and …

FDA’s No. 2 Official Sounds Off on Right to Try, Opioid Crisis

During his first State of the Union address two weeks ago, President Donald Trump expressed …

#BIOCEO18: Tackling the Opioid Crisis

Opioid addiction is plaguing communities across the country, leaving in its wake countless victims, devastated …

BIO Releases Report on Investment in Pain and Addiction Therapeutics

BIO’s Industry Analysis team has released its second report in a new series on the …

New Report Series Launched on The State of Innovation in Highly Prevalent Chronic Diseases

BIO’s Industry Analysis team has released its first report in a new series on the …

Jim Greenwood Talks Biotech Innovation With Bloomberg Radio

While in Boston this week, BIO CEO Jim Greenwood sat down with Bloomberg Boston Bureau …

Biomedical Innovation Can Help Solve the Opioid Crisis

Opioid abuse in America touches the lives of millions. It’s estimated that more than 1,000 …